
User fee programs have improved FDA’s approval timeline for important therapies.
Don Henry is director of the Office of Program and Regulatory Operations in FDA’s Center for Drug Evaluation and Research’s Office of Pharmaceutical Quality.

Published: May 2nd 2023 | Updated: